Skip to main content
. 2020 Apr 5;12(4):883. doi: 10.3390/cancers12040883

Figure 7.

Figure 7

Treatment with the CCR5 antagonist maraviroc blocks the migration and invasion of HCC cells. (A) Three-dimensional morphology of invading cells over a 5-days for HCC cells untreated and treated with maraviroc. (B) Representative images showing CCL5-induced migration and invasion of liver cancer cells. (C) Quantitative surface area analysis of HCC cells over 5-days. The experiments were repeated three times. Bar graphs are presented as a change in surface area in expression (±standard error); the asterisks indicate p values (* p < 0.05 ** p < 0.01).